电话:
+86 (0512) 65829739
传真:
+86 (010) 6788 5057
电子邮件:
orders@antibodies-online.cn

SARS-CoV-2 Antibodies

With the outbreak of COVID-19 in the Chinese city of Wuhan, infection prevention and control has become critical. Since 2006 antibodies-online.com serves Scientists and Research Institutions around the globe. To support SARS-CoV-2 research we put together a large collection of antibodies against different SARS-CoV-2 targets. Products for spike protein, membrane protein, envelope protein, nucleocapsid protein and non structural proteins are available. These antibodies can be used for detection of the virus in a variety of applications including IHC, ELISA, WB, IF staining. We also offer a set of neutralizing antibodies based on clone CR3022. Discover our SARS-CoV-2 antibody portfolio below.

Featured SARS-CoV-2 Antibodies used in Current Research

Product
Clonality
Clone
Protein Type
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Monoclonal
Clone CR3022
Protein Type Recombinant Antibody
Application ELISA, IF, Crys, SPR, mIHC
Cat. No. ABIN6952546
Validations
  • (8)
  • (15)
  • (1)
Quantity 200 μg
Datasheet Datasheet
Clonality Polyclonal
Clone
Protein Type
Application ELISA, WB, IF, FACS, FISH, IHC
Cat. No. ABIN6952544
Validations
  • (13)
  • (14)
Quantity 500 μg
Datasheet Datasheet
Clonality Polyclonal
Clone
Protein Type
Application ELISA, WB, IF, IHC
Cat. No. ABIN1030641
Validations
  • (9)
  • (11)
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Clone
Protein Type
Application ELISA, IHC, IF
Cat. No. ABIN1031551
Validations
  • (9)
  • (8)
Quantity 0.1 mg
Datasheet Datasheet
Clonality Chimeric
Clone CR3022
Protein Type Recombinant Antibody
Application ELISA, IF, Crys, SPR
Cat. No. ABIN6952547
Validations
  • (5)
  • (3)
Quantity 200 μg
Datasheet Datasheet
Targets for Coronavirus SARS-CoV-2 antibodies - antibodies-online.com

SARS-CoV-2 Spike Antibodies (S1, S2)

The SARS-CoV-2 spike protein protrudes from the envelope of the virion and plays a pivotal role in the receptor host selectivity and cellular attachment. Strong scientific evidence showed that SARS and SARS-CoV-2 spike proteins interact with angiotensin-converting enzyme 2 (ACE2).(1)

Below you will find a selection of our SARS-CoV-2 spike protein antibodies. Click on the links to see more details. See neutralizing S-protein antibodies based on clone CR3022

Product
Clonality
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Monoclonal
Application ELISA, IF, Crys, SPR, mIHC
Cat. No. ABIN6952546
Validations
  • (8)
  • (15)
  • (1)
Quantity 200 μg
Datasheet Datasheet
Clonality Monoclonal
Application ELISA, Neut
Cat. No. ABIN6952616
Validations
  • (7)
  • (10)
Quantity 100 μg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB, IF, IHC
Cat. No. ABIN1030641
Validations
  • (9)
  • (11)
Quantity 0.1 mg
Datasheet Datasheet
Clonality Chimeric
Application ELISA, IF, Crys, SPR
Cat. No. ABIN6952547
Validations
  • (5)
  • (3)
Quantity 200 μg
Datasheet Datasheet
Clonality Monoclonal
Application ELISA, Neut, GICA
Cat. No. ABIN6953152
Validations
  • (4)
Quantity 100 μL
Datasheet Datasheet
Clonality Monoclonal
Application ELISA
Cat. No. ABIN6953155
Validations
  • (1)
Quantity 100 μL
Datasheet Datasheet

See a complete SARS-CoV-2 S Antibody List

SARS-CoV-2 Nucleocapsid Antibodies

The nucleocapsid (N) protein is an important antigen for coronavirus, which participate in RNA package and virus particle release. After infection, the N protein enters the host cell together with the viral RNA to facilitate its replication and process the virus particle assembly and release. SARS-CoV-2 N protein contains two distinct RNA-binding domains (NTD and CTD) linked by a poorly structured linkage region containing a serine/arginine-rich (SR-rich) domain. (2) Below you will find a selection of our CoV SARS-CoV-2 nucleocapsid protein antibodies.

Rabbit Monoclonal SARS-CoV-2 N-Protein Antibodies

Rabbit monoclonals offer an improved immune response to small epitopes and a better response to mouse antigens. They give a better reaction to antigens than those from rodents such as mice. Because of their advantages rabbit monoclonal antibodies are becoming more preferred in research and clinical applications.

Product
Clonality
Clone
Protein Type
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Monoclonal
Clone DM54
Protein Type Recombinant Antibody
Application ELISA, FACS
Cat. No. ABIN6964062
Validations
  • (2)
Quantity 100 μg
Datasheet Datasheet

SARS-CoV-2 N-Protein Antibodies

Product
Clonality
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Polyclonal
Application ELISA, WB, IF, FACS, FISH, IHC
Cat. No. ABIN6952544
Validations
  • (13)
  • (14)
Quantity 500 μg
Datasheet Datasheet
Clonality Chimeric
Application ELISA, WB, GICA
Cat. No. ABIN6952664
Validations
  • (1)
  • (2)
Quantity 100 μL
Datasheet Datasheet
Clonality Chimeric
Application ELISA, IF
Cat. No. ABIN6953059
Validations
  • (3)
  • (2)
Quantity 200 μg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB
Cat. No. ABIN6952440
Validations
  • (1)
Quantity 100 μL
Datasheet Datasheet

See a complete SARS-CoV-2 N Antibody List

SARS-CoV-2 Envelope Protein Antibodies

The E protein is the smallest of the major structural proteins of SARS-CoV-2 and participates in viral assembly and budding. During the replication cycle, E is abundantly expressed inside the infected cell, but only a small portion is incorporated into the virion envelope. The majority of the protein is localised at the site of intracellular trafficking.(3) We currently offer two E-protein antibodies SARS-CoV-2 E-protein antibody ABIN1031551 and SARS-CoV-2 E-protein antibody ABIN6952904 .

Below you will find the available SARS-CoV-2 Envelope protein antibodies. Click on the links to see more details.

Product
Clonality
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Polyclonal
Application ELISA, IHC, IF
Cat. No. ABIN1031551
Validations
  • (9)
  • (8)
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application WB
Cat. No. ABIN7273009
Validations
  • (1)
Quantity 300 μg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB, IHC
Cat. No. ABIN6990142
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application
Cat. No. ABIN6992294
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB
Cat. No. ABIN6990014
Validations
Quantity 0.1 mg
Datasheet Datasheet

SARS-CoV-2 Membrane Protein Antibodies

The coronavirus membrane (M) protein is the key player in virion assembly. One of its functions is to mediate the incorporation of the spikes into the viral envelope. When expressed alone, it accumulates in the Golgi complex in homomultimeric complexes. However, in combination with the E protein, virus-like particles (VLPs) similar to authentic virions in size and shape are assembled, demonstrating that the M and E proteins are the minimal requirements for envelope formation.(4)

Product
Clonality
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Polyclonal
Application WB
Cat. No. ABIN7273018
Validations
  • (1)
Quantity 300 μg
Datasheet Datasheet
Clonality Polyclonal
Application WB
Cat. No. ABIN7273010
Validations
  • (1)
Quantity 300 μg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB, IHC
Cat. No. ABIN6990140
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB, IHC
Cat. No. ABIN6990136
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB
Cat. No. ABIN6990122
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB
Cat. No. ABIN6952906
Validations
  • (3)
Quantity 0.1 mg
Datasheet Datasheet

SARS-CoV-2 ORF Antibodies

Product
Clonality
Application
Cat. No.
Validations
Quantity
Datasheet
Clonality Polyclonal
Application WB
Cat. No. ABIN7272994
Validations
  • (2)
Quantity 300 μg
Datasheet Datasheet
Clonality Polyclonal
Application WB
Cat. No. ABIN7272993
Validations
  • (1)
Quantity 300 μg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA
Cat. No. ABIN6990152
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA
Cat. No. ABIN6992310
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA
Cat. No. ABIN6992305
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, IHC
Cat. No. ABIN6992306
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, IHC
Cat. No. ABIN6992301
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Polyclonal
Application ELISA, WB, IHC
Cat. No. ABIN6992307
Validations
Quantity 0.1 mg
Datasheet Datasheet
Clonality Monoclonal
Application WB, IF, ICC
Cat. No. ABIN7469591
Validations
Quantity 100 μL
Datasheet Datasheet
Clonality Polyclonal
Application WB, ELISA
Cat. No. ABIN6990038
Validations
Quantity 0.1 mg
Datasheet Datasheet

Neutralizing SARS-CoV-2 Antibody [CR3022]

Presently, we are offering a variety of recombinant NAbs against SARS-CoV-2 S1, based on clone CR3022. Click the link below to see all available CR3022 antibodies.

Recombinant SARS-CoV-2 Spike S1 抗体  (RBD) Recombinant SARS-CoV-2 Spike S1 抗体  (RBD) Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) (ABIN6952546)
  • Recombinant human neutralizing antibody against SARS-CoV-2.
  • Frequently used as reference in S-protein ELISAs and neutralization assays.
  • Binds a highly conserved epitope, not interefering with the S-protein
Recombinant SARS-CoV-2 Spike S1 抗体  (RBD) Recombinant SARS-CoV-2 Spike S1 抗体  (RBD) Recombinant SARS-CoV-2 Spike S1 抗体 (RBD) (ABIN6952547)
  • The chimeric SARS-CoV-2 S1 antibody (CR3022) binds the amino acids 318-510 in the S1 domain of the SARS-CoV-2 Spike protein as well as SARS-CoV-2 (COVID-19) Spike protein.
  • Epitope does not overlap with ACE2-Binding Site.
  • 7 PubMed References available.

See a complete list of our neutralizing antibodies

References

Florindo, Kleiner, Vaskovich-Koubi, Acúrcio, Carreira, Yeini, Tiram, Liubomirski, Satchi-Fainaro: "Immune-mediated approaches against COVID-19." in: Nature nanotechnology, Vol. 15, Issue 8, pp. 630-645, (2020) (PubMed).

Kandimalla, John, Abburi, Vallamkondu, Reddy: "Current Status of Multiple Drug Molecules, and Vaccines: An Update in SARS-CoV-2 Therapeutics." in: Molecular neurobiology, Vol. 57, Issue 10, pp. 4106-4116, (2020) (PubMed).

Ortega, Serrano, Pujol, Rangel: "Role of changes in SARS-CoV-2 spike protein in the interaction with the human ACE2 receptor: An in silico analysis." in: EXCLI journal, Vol. 19, pp. 410-417, (2020) (PubMed).

Thao, Labroussaa, Ebert, Vkovski, Stalder, Portmann, Kelly, Steiner, Holwerda, Kratzel, Gultom, Schmied, Laloli, Hüsser, Wider, Pfaender, Hirt, Cippà, Crespo-Pomar, Schröder, Muth, Niemeyer, Corman et al.: "Rapid reconstruction of SARS-CoV-2 using a synthetic genomics platform. ..." in: Nature, (2020) (PubMed).

Zeng, Liu, Ma, Zhao, Yang, Liu, Mohammed, Zhao, Yang, Xie, Ding, Ma, Weng, Gao, He, Jin: "Biochemical characterization of SARS-CoV-2 nucleocapsid protein." in: Biochemical and biophysical research communications, Vol. 527, Issue 3, pp. 618-623, (2020) (PubMed).

de Haan, Smeets, Vernooij, Vennema, Rottier: "Mapping of the coronavirus membrane protein domains involved in interaction with the spike protein." in: Journal of virology, Vol. 73, Issue 9, pp. 7441-52, (1999) (PubMed).

Lu, Zhao, Li, Niu, Yang, Wu, Wang, Song, Huang, Zhu, Bi, Ma, Zhan, Wang, Hu, Zhou, Hu, Zhou, Zhao, Chen, Meng, Wang, Lin, Yuan, Xie, Ma, Liu, Wang, Xu, Holmes, Gao, Wu, Chen, Shi, Tan: "Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding." in: Lancet (London, England), Vol. 395, Issue 10224, pp. 565-574, (2020) (PubMed).

Stefan Pellenz
Dr. Stefan Pellenz, PhD
Product Manager at antibodies-online.com

Goal-oriented, time line driven scientist, proficiently trained in different academic institutions in Germany, France and the USA. Experienced in the life sciences e-commerce environment with a focus on product development and customer relation management.

Go to author page
客服